Livzon Pharma Announces FY2025 Final Dividend of RMB14.3 per 10 Shares

Bulletin Express04-23

Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.3 per 10 shares for the financial year ended 31 December 2025, according to its updated cash dividend announcement released on 23 April 2026.

Shareholder approval is scheduled for 29 May 2026. The stock will trade ex-dividend on 16 June 2026, with the record date set for 17 June 2026. Eligible shareholders will receive payment on 13 July 2026.

For investors holding H-shares, the dividend will be paid in Hong Kong dollars; the exact HKD amount and exchange rate will be disclosed later. Share transfer documents must be lodged with Tricor Investor Services Limited by 16:30 on 17 June 2026 to qualify for the distribution. No book-closure period is required.

Withholding tax on the dividend ranges from 10% to 20% for non-resident enterprise shareholders registered outside the People’s Republic of China.

The announcement carries no information on warrants or convertible securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1194233623?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194233623","market":"us","top_or_hot":-1,"title":"Livzon Pharma Announces FY2025 Final Dividend of RMB14.3 per 10 Shares","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.3 per 10 shares for the financial year ended 31 December 2025, according to its updated cash dividend announcement released on 23 April 2026.</p>\n<p>Shareholder approval is scheduled for 29 May 2026. The stock will trade ex-dividend on 16 June 2026, with the record date set for 17 June 2026. Eligible shareholders will receive payment on 13 July 2026.</p>\n<p>For investors holding H-shares, the dividend will be paid in Hong Kong dollars; the exact HKD amount and exchange rate will be disclosed later. Share transfer documents must be lodged with Tricor Investor Services Limited by 16:30 on 17 June 2026 to qualify for the distribution. No book-closure period is required.</p>\n<p>Withholding tax on the dividend ranges from 10% to 20% for non-resident enterprise shareholders registered outside the People’s Republic of China.</p>\n<p>The announcement carries no information on warrants or convertible securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma Announces FY2025 Final Dividend of RMB14.3 per 10 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma Announces FY2025 Final Dividend of RMB14.3 per 10 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-23 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.3 per 10 shares for the financial year ended 31 December 2025, according to its updated cash dividend announcement released on 23 April 2026.</p>\n<p>Shareholder approval is scheduled for 29 May 2026. The stock will trade ex-dividend on 16 June 2026, with the record date set for 17 June 2026. Eligible shareholders will receive payment on 13 July 2026.</p>\n<p>For investors holding H-shares, the dividend will be paid in Hong Kong dollars; the exact HKD amount and exchange rate will be disclosed later. Share transfer documents must be lodged with Tricor Investor Services Limited by 16:30 on 17 June 2026 to qualify for the distribution. No book-closure period is required.</p>\n<p>Withholding tax on the dividend ranges from 10% to 20% for non-resident enterprise shareholders registered outside the People’s Republic of China.</p>\n<p>The announcement carries no information on warrants or convertible securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1194233623","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194233623","pubTimestamp":1776955427,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.3 per 10 shares for the financial year ended 31 December 2025, according to its updated cash dividend...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药公布2025财年末期股息每10股人民币14.3元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) declared a final ordinary dividend of RMB14.3 per 10 shares for the financial year ended 31 December 2025, according to its updated cash dividend announcement released on 23 April 2026.\nShareholder approval is scheduled for 29 May 2026. The stock will trade ex-dividend on 16 June 2026, with the record date set for 17 June 2026. Eligible shareholders will receive payment on 13 July 2026.\nFor investors holding H-shares, the dividend will be paid in Hong Kong dollars; the exact HKD amount and exchange rate will be disclosed later. Share transfer documents must be lodged with Tricor Investor Services Limited by 16:30 on 17 June 2026 to qualify for the distribution. No book-closure period is required.\nWithholding tax on the dividend ranges from 10% to 20% for non-resident enterprise shareholders registered outside the People’s Republic of China.\nThe announcement carries no information on warrants or convertible securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.4","shortVersion":"4.42.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1194233623","isCrawlerRequest":true}